Advisors Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.02M | Buy |
245,867
+44,180
| +22% | +$902K | 0.07% | 194 |
|
|
2025
Q1 | $4.04M | Buy |
201,687
+22,752
| +13% | +$455K | 0.06% | 207 |
|
|
2024
Q4 | $4.77M | Buy |
178,935
+11,008
| +7% | +$293K | 0.08% | 195 |
|
|
2024
Q3 | $4.79M | Buy |
167,927
+25,626
| +18% | +$731K | 0.08% | 191 |
|
|
2024
Q2 | $3.1M | Buy |
142,301
+1,186
| +0.8% | +$25.8K | 0.05% | 220 |
|
|
2024
Q1 | $3.13M | Buy |
141,115
+19,226
| +16% | +$426K | 0.06% | 219 |
|
|
2023
Q4 | $2.63M | Buy |
121,889
+4,999
| +4% | +$108K | 0.05% | 229 |
|
|
2023
Q3 | $1.97M | Buy |
116,890
+37,318
| +47% | +$630K | 0.05% | 226 |
|
|
2023
Q2 | $1.09M | Buy |
79,572
+48,513
| +156% | +$666K | 0.03% | 253 |
|
|
2023
Q1 | $706K | Sell |
31,059
-152
| -0.5% | -$3.46K | 0.02% | 265 |
|
|
2022
Q4 | $735K | Buy |
31,211
+4,316
| +16% | +$102K | 0.02% | 265 |
|
|
2022
Q3 | $607K | Buy |
26,895
+1,678
| +7% | +$37.9K | 0.02% | 299 |
|
|
2022
Q2 | $554K | Buy |
25,217
+7,587
| +43% | +$167K | 0.02% | 292 |
|
|
2022
Q1 | $791K | Buy |
17,630
+617
| +4% | +$27.7K | 0.02% | 264 |
|
|
2021
Q4 | $729K | Buy |
17,013
+2,901
| +21% | +$124K | 0.02% | 288 |
|
|
2021
Q3 | $938K | Buy |
14,112
+3,253
| +30% | +$216K | 0.03% | 245 |
|
|
2021
Q2 | $796K | Buy |
+10,859
| New | +$796K | 0.03% | 254 |
|